Shield Therapeutics’ place in the market and possible investment opportunities were explored by Proactive analyst Dr John Savin.
With a huge market in the US ready to be tapped into, Dr Savin explained how Shield is well-placed to make advances with their anaemia treatments, with a comparatively small team making in-roads and the chance to invest more to grab a larger share of the market in future.
